Type 2 diabetes is a chronic, metabolic disease mainly caused by resistance to insulin action and relative insulin deficiency, which lead to high blood glucose levels. Insulin resistance and hyperglycemia are major risk factors for vascular complications, including ischemic heart disease, diabetic nephropathy, retinopathy and neuropathy. Therefore, type 2 diabetes is recognized as one of the most important non-communicable diseases associated with an increased risk of both mortality and morbidity worldwide, affecting various demographics regardless of geographic location, age group, or gender.
The 2025 Learning Journey in Diabetes: a Case-Based Interactive Educational Experience is focusedon medical educational activities designed to build upon each other, creating a comprehensive and engaging learning experience for healthcare professionals focused on type 2 diabetes and insulin resistance. The progressive approach facilitates a deeper understanding and practical application of knowledge, ultimately improving patient outcomes.
